[NVIC] CDC New Child and Adolescent Immunization Schedule Unsafe

[Guest guest]

E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER

Vienna, Virginia http://www.nvic.org

* * * * * * * * * * * * * * * * * * * * * * *

UNITED WAY/COMBINED FEDERAL CAMPAIGN

#8122

* * * * * * * * * * * * * * * * * * * * * * *

" Protecting the health and informed consent rights of children since 1982. "

============================================================================

==============

BL Fisher Note:

There is no credible scientific evidence published by the CDC which

documents the safety and effectiveness of every child and adolescent

adhering to this new vaccination schedule.

Twenty-five years ago, the CDC told American parents to give their children

23 doses of 7 vaccines by age 5. Now the CDC is telling parents to give

their children 52 doses of 14 vaccines by age 12. And more vaccines are

being developed that will target children, especially adolescents.

Will anyone be monitoring potential increases in brain and immune system

dysfunction in children, including behavioral changes in adolescents who are

undergoing hormonal changes and who, for the first time, will be subjected

to new vaccines that can alter brain and immune system function? Or will

future increases in ADHD, learning disabilities, asthma, autistic behaviors,

diabetes, seizure disorders, irritable bowel and chronic fatigue syndrome,

depression, heart disease, cancer and other kinds of brain and immune system

disorders among adolescents be written of as " coincidentally " associated

with vaccination?

Where is the credible scientific research into the biological mechanisms

involved in vaccine associated brain and immune system dysfunction so that

vaccine induced pathology and genetic factors can be identified in order to

spare the lives of those at risk?

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5451-Immunizationa1.htm

CDC

Recommended Childhood and Adolescent Immunization Schedule --- United

States, 2006

Harmonized Childhood and Adolescent Immunization Schedule, 2006

The Advisory Committee on Immunization Practices (ACIP) periodically

reviews the recommended childhood and adolescent immunization schedule

to ensure that the schedule is current with changes in vaccine

formulations and reflects revised recommendations for the use of

licensed vaccines, including those newly licensed. The recommendations

and format of the childhood and adolescent immunization schedule and

catch-up schedule for January--December 2006 were approved by ACIP, the

American Academy of Pediatrics (AAP), and the American Academy of Family

Physicians (AAFP) (Figure

<http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5451-Immunizationa1.htm#fig>

and Table

<http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5451-Immunizationa1.htm#tab>).

The changes to the previous childhood and adolescent immunization

schedule, published January 2005 (/1

<http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5351-Immunizationa1.htm>/),

are as follows:

* The importance of the hepatitis B vaccine (HepB) birth dose has

been emphasized. Vaccination of infants born to hepatitis B

surface antigen (HBsAg)-negative mothers can be delayed in rare

circumstances, but only if a physician's order to withhold the

vaccine and a copy of the mother's original HBsAg-negative

laboratory report are documented in the infant's medical record.

Administering four doses of HepB is permissible (e.g., when

combination vaccines are administered after the birth dose);

however, if monovalent HepB is used, a dose at age 4 months is not

needed. For infants born to HBsAg-positive mothers, testing for

HBsAg and antibody to HBsAg after completion of the vaccine series

should be conducted at age 9--18 months (generally at the next

well-child visit after completion of the vaccine series).

* A new tetanus toxoid, reduced diphtheria toxoid, and acellular

pertussis vaccine recommended by ACIP for adolescents (Tdap

adolescent preparation) was approved by the Food and Drug

Administration (FDA) on May 5, 2005, for use in the United States.

Tdap is recommended for adolescents aged 11--12 years who have

completed the recommended childhood diphtheria and tetanus toxoids

and pertussis/diphtheria and tetanus toxoids and acellular

pertusis (DTP/DTaP) vaccination series and have not received a

tetanus and diphtheria toxoids (Td) booster dose. Adolescents aged

13--18 years who missed the age 11--12-year Td/Tdap booster dose

should also receive a single dose of Tdap if they have completed

the recommended childhood DTP/DTaP vaccination series. Subsequent

Td boosters are recommended every 10 years (/2/).

* Meningococcal conjugate vaccine (MCV4), approved by FDA on January

14, 2005, should be administered to all children at age 11--12

years as well as to unvaccinated adolescents at high school entry

(age 15 years). Other adolescents who wish to decrease their risk

for meningococcal disease may also be vaccinated. All college

freshmen living in dormitories should also be vaccinated with MCV4

or meningococcal polysaccharide vaccine (MPSV4). For prevention of

invasive meningococcal disease, vaccination with MPSV4 for

children aged 2--10 years and with MCV4 for older children in

certain high-risk groups is recommended (/3

<http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5407a1.htm>/).

* Influenza vaccine is now recommended for children aged _>_6 months

with certain risk factors, which now specifically include

conditions that can compromise respiratory function or handling of

respiratory secretions or that can increase the risk for

aspiration (/4

<http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5408a1.htm>/).

* Hepatitis A vaccine is now universally recommended for all

children at age 1 year (12--23 months). The 2 doses in the series

should be administered at least 6 months apart.

* The catch-up schedule for persons aged 7--18 years has been

changed for Td; Tdap may be substituted for any dose in a primary

catch-up series or as a booster if age appropriate for Tdap. A

5-year interval from the last Td dose is encouraged when Tdap is

used as a booster dose.

=============================================

News@... is a free service of the National Vaccine Information

Center and is supported through membership donations. Learn more about

vaccines, diseases and how to protect your informed consent rights

http://www.nvic.org

Become a member and support NVIC's work

https://www.nvic.org/making%20cash%20donations.htm

To sign up for a free e-mail subscription http://www.nvic.org/emaillist.htm